1142936-98-8

Basic information

• Product Name: 4-[2-(cyclopropanecarbonylamino)-[1,2,4]triazolo[1,5-a]pyridin-5-yl]benzoic acid
• Synonyms: 4-[2-(cyclopropanecarbonylamino)-[1,2,4]triazolo[1,5-a]pyridin-5-yl]benzoic acid
• CAS NO: 1142936-98-8
• Molecular Weight: 322.323
• Mol File: 1142936-98-8.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: 4-[2-(cyclopropanecarbonylamino)-[1,2,4]triazolo[1,5-a]pyridin-5-yl]benzoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 4-[2-(cyclopropanecarbonylamino)-[1,2,4]triazolo[1,5-a]pyridin-5-yl]benzoic acid(1142936-98-8)
• EPA Substance Registry System: 4-[2-(cyclopropanecarbonylamino)-[1,2,4]triazolo[1,5-a]pyridin-5-yl]benzoic acid(1142936-98-8)

Safety Data

• Hazardous Substances Data: 1142936-98-8(Hazardous Substances Data)

Usage

General Description

4-[2-(cyclopropanecarbonylamino)-[1,2,4]triazolo[1,5-a]pyridin-5-yl]benzoic acid is a chemical compound with potential therapeutic effects. It has been studied for its potential as a pharmaceutical agent due to its structural properties and potential activity against certain biological targets. The compound contains a benzene ring attached to a carboxylic acid group, as well as a cyclopropane carbonyl group and a triazolo pyridine ring. These structural elements suggest that the compound may possess certain pharmacological activities, and it could be further studied for its potential use in drug development and medical research.

Upstream product

• 1010120-59-8 ethyl N-[(6-bromopyridin-2-yl)carbamothioyl]carbamate 
• 1142943-96-1 cyclopropanecarboxylic acid (5-bromo-[1,2,4]triazolo[1,5-a]pyridin-2-yl)-amide 
• 14047-29-1 4-carboxyphenylboronic acid 
• 180516-87-4 4-carboxyphenylboronic acid pinacol ester 
• 1010120-55-4 5-Bromo-[1,2,4]Triazolo[1,5-a]pyridine-2-ylamine 

Downstream Products

• 1206163-53-2 4-[2-(cyclopropanecarbonylamino)-[1,2,4]-triazolo[1,5-a]pyridin-5-yl]benzoyl chloride 

Relevant articles and documents

Triazolo pyridine compound and preparation method, medicinal composition and application thereof

The invention discloses a triazolo pyridine compound as well as a preparation method, a medicinal composition and application thereof. The compound is selected from a compound shown in a general formula I, or a tautomer, an enantiomer, a diastereoisomer,

Triazolopyridines as selective JAK1 inhibitors: From hit identification to GLPG0634

Janus kinases (JAK1, JAK2, JAK3, and TYK2) are involved in the signaling of multiple cytokines important in cellular function. Blockade of the JAK-STAT pathway with a small molecule has been shown to provide therapeutic immunomodulation. Having identified

[1,2,4]TRIAZOLO[1,5-A]PYRIDINE AND [1,2,4]TRIAZOLO[1,5-C]PYRIMIDINE COMPOUNDS AND THEIR USE

The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain triazolo compounds (referred to herein as TAZ compounds), and especially certain [1,2,4]triazolo[1,5-a]pyridine and [1,2,4]triazolo[1,5-c]pyri